| # | Title | Journal | Year | Citations |
|---|
| 1 | A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer | Nature Medicine | 2012 | 510 |
| 2 | SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group | Blood | 2012 | 361 |
| 3 | Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity | Journal of Clinical Oncology | 2006 | 334 |
| 4 | Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma | Gut | 2012 | 307 |
| 5 | Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study | Annals of Oncology | 2020 | 253 |
| 6 | A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures | Immunity | 2016 | 232 |
| 7 | Comparison of hepatocellular carcinoma in Eastern versus Western populations | Cancer | 2016 | 221 |
| 8 | Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas | Gut | 2015 | 197 |
| 9 | Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore | Modern Pathology | 2004 | 174 |
| 10 | Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison | British Journal of Cancer | 2005 | 161 |
| 11 | Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy | Journal of Oncology | 2012 | 144 |
| 12 | Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer | Annals of Oncology | 2019 | 141 |
| 13 | Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies | Annals of Oncology | 2015 | 138 |
| 14 | Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma | Annals of Oncology | 1999 | 134 |
| 15 | Type II enteropathy‐associated T‐cell lymphoma: A multicenter analysis from the Asia Lymphoma Study Group | American Journal of Hematology | 2012 | 134 |
| 16 | Distinct clinical features and outcomes in never‐smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement | Cancer | 2012 | 132 |
| 17 | High SUV uptake on FDG–PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG–PET/CT staging in lymphoma | Annals of Oncology | 2009 | 131 |
| 18 | RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma | Journal of Cellular and Molecular Medicine | 2009 | 128 |
| 19 | The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer | Chest | 2004 | 127 |
| 20 | Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma | British Journal of Cancer | 2010 | 127 |
| 21 | Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer | Journal of Clinical Oncology | 2003 | 122 |
| 22 | Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer | Breast Cancer Research and Treatment | 2016 | 122 |
| 23 | Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients | Cancer Science | 2008 | 121 |
| 24 | Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009 | Lancet Oncology, The | 2009 | 121 |
| 25 | Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type | Annals of Oncology | 2002 | 118 |
| 26 | A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer | Annals of Oncology | 2012 | 116 |
| 27 | Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection | Scientific Reports | 2021 | 116 |
| 28 | Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype | Leukemia | 2013 | 115 |
| 29 | Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab | Annals of Hematology | 2011 | 114 |
| 30 | Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial | Lancet Oncology, The | 2022 | 111 |
| 31 | Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura | British Journal of Haematology | 2005 | 110 |
| 32 | A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma | Annals of Oncology | 2012 | 110 |
| 33 | Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients | British Journal of Clinical Pharmacology | 2011 | 107 |
| 34 | Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer | American Journal of Clinical Pathology | 2010 | 99 |
| 35 | Design of a prognostic index score for metastatic nasopharyngeal carcinoma | European Journal of Cancer | 2003 | 98 |
| 36 | Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab | Leukemia and Lymphoma | 2008 | 95 |
| 37 | Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer | British Journal of Clinical Pharmacology | 2005 | 93 |
| 38 | Role of inflammatory infiltrates in triple negative breast cancer: Table 1 | Journal of Clinical Pathology | 2015 | 89 |
| 39 | Pharmacokinetics of (glycolato-0,0?)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin | Cancer Chemotherapy and Pharmacology | 1989 | 88 |
| 40 | AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC) | Journal of Hepatology | 2010 | 88 |
| 41 | Ten-year survival in women with primary stage IV breast cancer | Breast Cancer Research and Treatment | 2016 | 88 |
| 42 | Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations | Journal of Thoracic Oncology | 2016 | 87 |
| 43 | NovelSLC22A16polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients | Pharmacogenomics | 2007 | 85 |
| 44 | Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis | Lancet Haematology,the | 2015 | 85 |
| 45 | Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma | Cancer | 2005 | 77 |
| 46 | Prognostic Significance of Glutathione S-Transferase-Pi in Invasive Breast Cancer | Modern Pathology | 2003 | 75 |
| 47 | Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group | Bone Marrow Transplantation | 2014 | 74 |
| 48 | The relationship of hepatitis B virus infection and non-Hodgkin?s lymphoma and its impact on clinical characteristics and prognosis | European Journal of Haematology | 2007 | 69 |
| 49 | Association between psychological symptoms in adults and growth in early life: longitudinal follow up study | BMJ: British Medical Journal | 2002 | 68 |
| 50 | The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients | Cancer Chemotherapy and Pharmacology | 2011 | 67 |
